ArticleAfrican health sciences2025
Erythropoietic indices in asthma patients on controller medications: a comparative analysis.
Article in African health sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Editorial: Infections, reproductive health and non-communicable diseases.African health sciences · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: A key feature of asthma is hypoxia, which triggers erythropoietin (EPO) production to stimulate erythropoiesis and compensate for oxygen deficits. This study investigates the impact of asthma controller medications on erythropoietic response by evaluating serum EPO levels and reticulocyte counts among asthma patients at Murtala Muhammad Specialist Hospital, Kano. Methodology: This study is a comparative cross-sectional study involving 180 participants, comprising 60 asthmatics on controller medications, 60 treatment-naive patients with asthma, and 60 apparently healthy controls. Serum EPO levels were determined by ELISA, while complete blood count (CBC) and reticulocyte count were determined by automated hematology analyzer and manual method, respectively. Results: The study revealed significant differences in EPO levels (p = 0.00001), reticulocyte counts (p = 0.0004), and hematological parameters (p = 0.009) among the three groups. Treatment-naive asthmatics exhibited elevated reticulocyte counts (2.50 (IQR: 3.50)) and EPO levels (38.88 mIU/mL (IQR: 25.6 mIU/mL)), suggesting enhanced erythropoiesis in response to hypoxia. In contrast, asthmatics on controller medications showed a negative correlation (ϱ = - 0.564) between EPO levels and reticulocyte counts, indicating a potential suppressive effect of corticosteroids on erythropoiesis. Conclusion: Asthma is associated with increased erythropoietin production; it is however suppressed by inhaled corticosteroid therapy.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.